FDA approves Boston Scientific's thrombectomy system:
This article was originally published in Clinica
The US FDA has approved Boston Scientific's Oasis thrombectomy system is designed to remove blood clots which develop in the access grafts of haemodialysis patients. A low-pressure water jet breaks down the blood clot and washes away the debris from the haemodialysis graft. The system can be used with a standard angiographic injector, said the company.
You may also be interested in...
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.
Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.